A strong association between grade ≥2 rash and nevirapine-based treatment was observed when only subjects with CD4+ >250 cells/mm3 were considered (P = 0.001), suggesting an interaction between the treatment and the CD4+ count [42]. This evidence concerns the gene CD4 and exanthem.